We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+20.64%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
10 Year Est. Return
AUM
$265M
AUM Growth
+$27M
Cap. Flow
-$20.6M
Cap. Flow %
-7.77%
Top 10 Hldgs %
60.48%
Holding
196
New
11
Increased
11
Reduced
19
Closed
23

Top Buys

Rank Stock Value
1
OABI icon
OmniAb
OABI
+$6.67M
2
CSX icon
CSX Corp
CSX
+$2.11M
3
CLMT icon
Calumet Specialty Products
CLMT
+$1.85M
4
SNY icon
Sanofi
SNY
+$1.58M
5
ARDX icon
Ardelyx
ARDX
+$1.44M

Sector Composition

Rank Sector Weight
1 Materials 29.69%
2 Healthcare 28.82%
3 Financials 9.61%
4 Consumer Staples 6.03%
5 Real Estate 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VXX icon
51
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$161M
$706K 0.27%
3,125
-3,125
-50% -$856K
CTVA icon
52
Corteva
CTVA
$58.6B
$680K 0.26%
11,563
FAZEW
53
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$671K 0.25%
58,321
XAIR icon
54
Beyond Air
XAIR
$3.87M
$649K 0.25%
+250
New +$640K
KO icon
55
Coca-Cola
KO
$362B
$611K 0.23%
9,600
DOW icon
56
Dow Inc
DOW
$20.8B
$561K 0.21%
11,136
ADMA icon
57
ADMA Biologics
ADMA
$1.97B
$513K 0.19%
132,301
-20,000
-13% -$61.7K
WPC icon
58
W.P. Carey
WPC
$17B
$469K 0.18%
6,126
-6,126
-50% -$460K
ABEO icon
59
Abeona Therapeutics
ABEO
$349M
$462K 0.17%
+150,000
New +$561K
CAG icon
60
Conagra Brands
CAG
$7.29B
$387K 0.15%
10,000
MSFT icon
61
Microsoft
MSFT
$2.89T
$384K 0.15%
1,600
CYPH
62
Cypherpunk Technologies Inc
CYPH
$66.7M
$378K 0.14%
84,000
-6,000
-7% -$40.1K
BRSL
63
Brightstar Lottery PLC
BRSL
$1.93B
$374K 0.14%
16,500
IBER
64
DELISTED
Ibere Pharmaceuticals
IBER
$363K 0.14%
36,000
CNQ icon
65
Canadian Natural Resources
CNQ
$93.4B
$355K 0.13%
12,800
ACER
66
DELISTED
Acer Therapeutics Inc
ACER
$351K 0.13%
+140,000
New +$240K
WHWK
67
Whitehawk Therapeutics
WHWK
$183M
$350K 0.13%
27,242
-21,797
-44% -$285K
AAPL icon
68
Apple
AAPL
$4.95T
$324K 0.12%
2,494
PSQH.WS icon
69
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.08M
$307K 0.12%
26,666
QTEKW
70
DELISTED
QualTek Services Inc. Warrant
QTEKW
$288K 0.11%
25,000
FSK icon
71
FS KKR Capital
FSK
$3.04B
$266K 0.1%
15,175
MSACW
72
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$256K 0.1%
22,222
XOMA
73
DELISTED
Xoma
XOMA
$210K 0.08%
+11,425
New +$208K
IBER.WS
74
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
$207K 0.08%
18,000
INCY icon
75
Incyte
INCY
$23.7B
$205K 0.08%
2,557
-13,700
-84% -$1.05M

Similar funds

David M. Knott Jr's Q4 2022 Portfolio in Review

As of Q4 2022, David M. Knott Jr held 196 positions worth $265M, up 11% from $238M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

David M. Knott Jr withdrew a net $20.6M in Q4 2022, closing 23 positions and reducing 19 holdings. Its most notable exit was Eiger BioPharmaceuticals, Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Materials at 30% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, David M. Knott Jr opened a new position in OmniAb worth $4.58M.

  • David M. Knott Jr's largest Q4 2022 buy was OmniAb: 1,270,939 shares worth $4.58M.
  • David M. Knott Jr added most to Calumet Specialty Products in Q4 2022, an estimated $1.85M increase.
  • David M. Knott Jr's biggest Q4 2022 reduction was Ligand Pharmaceuticals, cutting an estimated $4.51M.
  • David M. Knott Jr fully exited Eiger BioPharmaceuticals, Inc. in Q4 2022, selling an estimated $3.08M.
  • David M. Knott Jr's ten largest holdings make up 60% of its $265M portfolio in Q4 2022.
  • David M. Knott Jr opened 11 new positions and closed 23 in Q4 2022.
  • David M. Knott Jr's portfolio value rose 11% quarter-over-quarter to $265M.

Based on David M. Knott Jr's 13F filing for Q4 2022, filed 13 Feb 2023.